A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease

Neilson, Kate; Ftanou, Maria; Monshat, Kaveh; Salzberg, Mike; Bell, Sally; Kamm, Michael A.; Connell, William; Knowles, Sandra R.; Sevar, Katherine; Mancuso, Serafino G.; Castle, David

doi:10.1097/mib.0000000000000629

Cited by 70 publications

(52 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A recent study comparing MBT to waitlist control found that the mindfulness group reported significant improvements in anxiety, quality of life, and depression when compared to the control group. 75 This study also found that these effects persisted at 6-month follow-up. Other studies have produced compelling but less clear results.…”

Section: Mindfulnesssupporting

confidence: 62%

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases

Ballou

Keefer

2017

Clinical and Translational Gastroenterology

133

View full text Add to dashboard Cite

Psychological interventions have been designed and implemented effectively in a wide range of medical conditions, including Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Diseases (IBD). The psychological treatments for IBS and IBD with the strongest evidence base include: cognitive behavioral therapy, hypnosis, and mindfulness-based therapies. The evidence for each of these therapies is reviewed here for both IBS and IBD. In general, there is a stronger and larger evidence base to support the use of psychological interventions in IBS compared with IBD. This is likely due to the high level of psychiatric comorbidity associated with IBS and the involvement of the stress-response in symptom presentation of IBS. Further research in psychosocial interventions for IBD is necessary. Finally, the importance of conceptualizing both IBS and IBD in a biopsychosocial model is discussed and several resources for accessing Clinical Health Psychology materials and referrals are provided.

show abstract

Section: Mindfulnesssupporting

confidence: 62%

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases

Ballou

Keefer

2017

Clinical and Translational Gastroenterology

133

View full text Add to dashboard Cite

show abstract

“…7,8 Many groups have explored the benefits of educational interventions on patient knowledge, including prior studies of workshops, lectures, handbooks, group sessions, and face-to-face instruction. [12][13][14][15][16][17] One of the first studies, done across 9 communities in the United States, offered workshops with associated questionnaires and face-to-face sessions with patients and their families. 4 Although less than 10% of participants completed all questionnaires, significant improvements were demonstrated in participants' IBD knowledge, which were maintained for at least 3 months.…”

Section: Introductionmentioning

confidence: 99%

Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year

Abutaleb

Buchwald

Chudy-Onwugaje

et al. 2018

Inflammatory Bowel Diseases

View full text Add to dashboard Cite

Telemedicine improves IBD-specific knowledge through text messaging, although the improvement is not additive with greater frequency of text messages. However, after adjustment for confounding variables, telemedicine is not superior to education given through standard visits at referral centers. Further research is needed to determine if revised systems with different modes of delivery and/or frequency of messages improve disease knowledge.

show abstract

“…This project includes different professionals interacting to create an integrated exchange of competences. Patients can therefore take advantage of gastroenterological, surgical together with psychiatric check-ups, as well as psychological counseling with cognitive-behavioral orientation, for the most part based on the mindfulness approach ( 79 ). In our experience, in less than 2 years the GE.Co Project has involved about 50 patients which have been receiving both pharmacological and psychological treatment.…”

Section: Ethics and Disseminationmentioning

confidence: 99%

Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies

et al. 2018

View full text Add to dashboard Cite

Comorbidity with anxiety or depression is common in patients with Inflammatory Bowel Disease (IBD) as Crohn Disease (CD) and Ulcerative Colitis (UC). Data suggest that the cognitive construct of alexithymia has high prevalence in people suffering from anxiety and mood disorders and even in people with IBD. Most studies have investigated mainly anxiety and depression, considering IBD population as a homogeneous group of patients. Little evidence shows the impact of alexithymia on the course of IBD. We evaluated a broad spectrum of psychopathological symptoms and alexithymia levels in a group of outpatients affected by IBD in clinical remission, comparing CD and UC and investigating the relationship with clinical and socio-demographic variables. One hundred and seventy IBD outpatients were screened by using the Hospital Anxiety Depression Scale (HADS), the Self-report Symptom Inventory-90-Revised (SCL-90-R) and the Toronto Alexithymia Scale (TAS-20). A high prevalence of anxious and depressive symptoms (42.35 and 25.8% respectively) together with alexithymia (31.76%) was confirmed. CD patients experienced high levels of depression (HADS Depression 35.2% p = 0.034; SCL-90-R mean 1.39 p < 0.001), somatisation (SCL-90-R mean 1.04 p < 0.001), obsessive-compulsive symptoms (SCL-90-R mean 1.2 p < 0.001), and global severity (SCL-90-R mean 1.15 p < 0.001). There is no statistical difference in the prevalence of alexithymia in both subpopulations. The levels of alexithymia are correlated to the levels of anxiety (HADS Anxiety rs = 0.516 p < 0.001), depression (HADS Depression rs = 0.556 p < 0.001; SCL-90-R rs = 0.274 p = 0.001), somatisation (SCL-90-R rs = 0.229 p = 0.005), obsessive-compulsive symptoms (SCL-90-R rs = 0.362 p < 0.001), and global severity (SCL-90-R rs = 0.265 p = 0.001). Furthermore, alexithymia is associated with a delay of diagnosis of IBD, poly-therapies and greater IBD extension. Older age, female gender, greater IBD extension, surgery, and delay of diagnosis seem to be related to a high prevalence of psychopathological symptoms such as anxiety, depression, somatisation, and obsessive-compulsive symptoms. Psychopathological symptoms and high levels of alexithymia are frequent in IBD patients and seem to be related to a high risk of poor clinical outcome. CD patients could be considered at higher risk of mental comorbidity. A more comprehensive psychiatric assessment, including alexithymia, and an integrated treatment of underlying conditions, must be taken into account in order to improve the global prognosis of the disease.

show abstract

A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease

Abstract: Results demonstrate the feasibility, acceptability, and efficacy of a mindfulness intervention for patients with inflammatory bowel disease, with medium-to-large effects on psychological distress, quality of life, and mindfulness.

Cited by 70 publications

References 43 publications

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases

Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year

Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies

Contact Info

Product

Resources

About